Cargando…

Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico

To our knowledge, this is the first study reported in the literature that has validated the Norma Latina Battery in a population of people with Alzheimer’s disease (AD) in Mexico. The objective of the study was to determine the discriminant validity of the Norma Latina Battery in a group of Mexican...

Descripción completa

Detalles Bibliográficos
Autores principales: Núñez-Fernández, Silvia, Rivera, Diego, Arroyo-Anlló, Eva María, Ortiz Jiménez, Xóchitl Angélica, Camino-Pontes, Borja, Salinas Martínez, Ricardo, Arango-Lasprilla, Juan Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517570/
https://www.ncbi.nlm.nih.gov/pubmed/36141594
http://dx.doi.org/10.3390/ijerph191811322
_version_ 1784798975889506304
author Núñez-Fernández, Silvia
Rivera, Diego
Arroyo-Anlló, Eva María
Ortiz Jiménez, Xóchitl Angélica
Camino-Pontes, Borja
Salinas Martínez, Ricardo
Arango-Lasprilla, Juan Carlos
author_facet Núñez-Fernández, Silvia
Rivera, Diego
Arroyo-Anlló, Eva María
Ortiz Jiménez, Xóchitl Angélica
Camino-Pontes, Borja
Salinas Martínez, Ricardo
Arango-Lasprilla, Juan Carlos
author_sort Núñez-Fernández, Silvia
collection PubMed
description To our knowledge, this is the first study reported in the literature that has validated the Norma Latina Battery in a population of people with Alzheimer’s disease (AD) in Mexico. The objective of the study was to determine the discriminant validity of the Norma Latina Battery in a group of Mexican individuals with AD and a group of heathy controls (HC). The Norma Latina Battery was administered to 234 Mexican participants (117 HC and 117 individuals with AD). Results show that: (1) the Norma Latina Battery has high discriminative capacity between groups in all domains; (2) participants with AD presented worse scores in each of the cognitive domains compared to the HC and a greater number of low scores in each of the established thresholds or cut-off points; and finally, (3) the Norma Latina Battery had optimal sensitivity and specificity, especially when a set was observed ≥5 scores below the 10th percentile or ≥4 scores below the 5th percentile. In conclusion, it is recommended that both clinicians and researchers use this battery in the evaluation of Mexican people with AD to better understand the prognosis of the disease and its subsequent treatment.
format Online
Article
Text
id pubmed-9517570
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95175702022-09-29 Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico Núñez-Fernández, Silvia Rivera, Diego Arroyo-Anlló, Eva María Ortiz Jiménez, Xóchitl Angélica Camino-Pontes, Borja Salinas Martínez, Ricardo Arango-Lasprilla, Juan Carlos Int J Environ Res Public Health Article To our knowledge, this is the first study reported in the literature that has validated the Norma Latina Battery in a population of people with Alzheimer’s disease (AD) in Mexico. The objective of the study was to determine the discriminant validity of the Norma Latina Battery in a group of Mexican individuals with AD and a group of heathy controls (HC). The Norma Latina Battery was administered to 234 Mexican participants (117 HC and 117 individuals with AD). Results show that: (1) the Norma Latina Battery has high discriminative capacity between groups in all domains; (2) participants with AD presented worse scores in each of the cognitive domains compared to the HC and a greater number of low scores in each of the established thresholds or cut-off points; and finally, (3) the Norma Latina Battery had optimal sensitivity and specificity, especially when a set was observed ≥5 scores below the 10th percentile or ≥4 scores below the 5th percentile. In conclusion, it is recommended that both clinicians and researchers use this battery in the evaluation of Mexican people with AD to better understand the prognosis of the disease and its subsequent treatment. MDPI 2022-09-08 /pmc/articles/PMC9517570/ /pubmed/36141594 http://dx.doi.org/10.3390/ijerph191811322 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Núñez-Fernández, Silvia
Rivera, Diego
Arroyo-Anlló, Eva María
Ortiz Jiménez, Xóchitl Angélica
Camino-Pontes, Borja
Salinas Martínez, Ricardo
Arango-Lasprilla, Juan Carlos
Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico
title Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico
title_full Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico
title_fullStr Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico
title_full_unstemmed Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico
title_short Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico
title_sort validation of the norma latina neuropsychological assessment battery in patients with alzheimer’s disease in mexico
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517570/
https://www.ncbi.nlm.nih.gov/pubmed/36141594
http://dx.doi.org/10.3390/ijerph191811322
work_keys_str_mv AT nunezfernandezsilvia validationofthenormalatinaneuropsychologicalassessmentbatteryinpatientswithalzheimersdiseaseinmexico
AT riveradiego validationofthenormalatinaneuropsychologicalassessmentbatteryinpatientswithalzheimersdiseaseinmexico
AT arroyoanlloevamaria validationofthenormalatinaneuropsychologicalassessmentbatteryinpatientswithalzheimersdiseaseinmexico
AT ortizjimenezxochitlangelica validationofthenormalatinaneuropsychologicalassessmentbatteryinpatientswithalzheimersdiseaseinmexico
AT caminopontesborja validationofthenormalatinaneuropsychologicalassessmentbatteryinpatientswithalzheimersdiseaseinmexico
AT salinasmartinezricardo validationofthenormalatinaneuropsychologicalassessmentbatteryinpatientswithalzheimersdiseaseinmexico
AT arangolasprillajuancarlos validationofthenormalatinaneuropsychologicalassessmentbatteryinpatientswithalzheimersdiseaseinmexico